Agenus' stock spikes 25% on promising data from brain cancer trial
December 16, 2013 at 10:40 AM EST
Lexington biotech Agenus’ stock spiked 25 percent this morning after one of its vaccines showed effectiveness against brain cancer, one of the areas of the disease that U...
